Eversept Partners
Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UTHR, QQQ, ABVX, GSK, VERA, and represent 30.82% of Eversept Partners's stock portfolio.
- Added to shares of these 10 stocks: BKD (+$44M), QGEN (+$41M), SPY (+$40M), VRTX (+$40M), WELL (+$36M), DOC (+$33M), ABVX (+$31M), OHI (+$26M), TLT (+$17M), INSM (+$15M).
- Started 40 new stock positions in EQ, PRAX, RGEN, CMPS, DFTX, EVMN, LTC, ENSG, HYG, DOC.
- Reduced shares in these 10 stocks: GSK (-$49M), DHR (-$43M), VERA (-$36M), , BRKR (-$24M), CDTX (-$22M), VRDN (-$21M), TEVA (-$21M), TVTX (-$19M), PCVX (-$16M).
- Sold out of its positions in ACAD, ELV, Ascendis Pharma A S, BIIB, BMY, CVS, CPRX, CBLL, CGON, CDTX.
- Eversept Partners was a net seller of stock by $-5.6M.
- Eversept Partners has $1.9B in assets under management (AUM), dropping by -4.43%.
- Central Index Key (CIK): 0001697013
Tip: Access up to 7 years of quarterly data
Positions held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eversept Partners
Eversept Partners holds 117 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 8.3 | $157M | +4% | 264k | 592.98 |
|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 7.3 | $138M | +6% | 239k | 577.18 |
|
| Abivax Sa Sponsored Ads (ABVX) | 5.5 | $104M | +42% | 934k | 111.35 |
|
| GSK Sponsored Adr (GSK) | 5.2 | $99M | -33% | 1.8M | 55.19 |
|
| Vera Therapeutics Cl A (VERA) | 4.6 | $87M | -29% | 2.2M | 40.23 |
|
| Natera (NTRA) | 4.1 | $77M | +15% | 385k | 199.99 |
|
| State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY) | 3.7 | $70M | +138% | 107k | 650.34 |
|
| Syndax Pharmaceuticals (SNDX) | 3.6 | $67M | -12% | 2.9M | 23.36 |
|
| Celldex Therapeutics Com New (CLDX) | 3.0 | $57M | +24% | 1.8M | 31.72 |
|
| Vaxcyte (PCVX) | 2.8 | $54M | -22% | 924k | 58.11 |
|
| Brookdale Senior Living (BKD) | 2.6 | $49M | +851% | 3.6M | 13.68 |
|
| Ionis Pharmaceuticals (IONS) | 2.5 | $48M | +17% | 632k | 75.09 |
|
| Qiagen Nv Ord Shares (QGEN) | 2.2 | $41M | NEW | 1.0M | 40.04 |
|
| Vertex Pharmaceuticals Incorporated Call Option (VRTX) | 2.1 | $40M | NEW | 90k | 446.54 |
|
| Hca Holdings (HCA) | 2.0 | $38M | -17% | 79k | 473.24 |
|
| Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT) | 2.0 | $37M | +86% | 429k | 86.69 |
|
| Welltower Inc Com reit (WELL) | 1.9 | $36M | NEW | 181k | 197.71 |
|
| Peak (DOC) | 1.7 | $33M | NEW | 2.0M | 16.43 |
|
| Insulet Corporation (PODD) | 1.6 | $30M | +92% | 144k | 209.84 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.5 | $29M | 3.0M | 9.52 |
|
|
| Geron Corporation (GERN) | 1.5 | $28M | +6% | 19M | 1.49 |
|
| Omega Healthcare Investors (OHI) | 1.4 | $26M | NEW | 586k | 43.82 |
|
| Liquidia Corporation Com New (LQDA) | 1.3 | $26M | +32% | 677k | 37.74 |
|
| Community Health Systems (CYH) | 1.3 | $26M | +9% | 8.7M | 2.94 |
|
| Avantor (AVTR) | 1.2 | $23M | -6% | 3.0M | 7.84 |
|
| Encompass Health Corp (EHC) | 1.0 | $19M | +81% | 194k | 96.73 |
|
| Eli Lilly & Co. (LLY) | 0.9 | $18M | +78% | 19k | 919.77 |
|
| Travere Therapeutics (TVTX) | 0.9 | $16M | -53% | 543k | 29.71 |
|
| Insmed Com Par $.01 Call Option (INSM) | 0.8 | $15M | NEW | 94k | 163.52 |
|
| Cytomx Therapeutics (CTMX) | 0.8 | $15M | +27% | 3.2M | 4.70 |
|
| Ishares Tr Iboxx Hi Yd Etf Put Option (HYG) | 0.8 | $14M | NEW | 180k | 79.56 |
|
| Repligen Corporation (RGEN) | 0.8 | $14M | NEW | 121k | 117.82 |
|
| Beta Bionics (BBNX) | 0.7 | $14M | +108% | 1.4M | 10.02 |
|
| Miragen Therapeutics (VRDN) | 0.7 | $14M | -59% | 713k | 19.56 |
|
| Arcutis Biotherapeutics (ARQT) | 0.7 | $14M | +32% | 577k | 23.56 |
|
| Ardelyx (ARDX) | 0.7 | $13M | +29% | 2.2M | 5.99 |
|
| LTC Properties (LTC) | 0.6 | $12M | NEW | 321k | 37.16 |
|
| BioMarin Pharmaceutical (BMRN) | 0.6 | $12M | +121% | 208k | 56.49 |
|
| Chemed Corp Com Stk (CHE) | 0.6 | $12M | NEW | 31k | 377.74 |
|
| Pharvaris N V (PHVS) | 0.6 | $12M | -7% | 407k | 28.25 |
|
| UnitedHealth Call Option (UNH) | 0.6 | $11M | -34% | 40k | 270.59 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 0.5 | $9.9M | NEW | 40k | 248.00 |
|
| Pennant Group (PNTG) | 0.5 | $9.5M | +6% | 312k | 30.48 |
|
| Select Sector Spdr Tr State Street Tec Put Option (XLK) | 0.5 | $9.3M | NEW | 70k | 132.90 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $9.1M | -32% | 286k | 32.01 |
|
| Palisade Bio (PALI) | 0.5 | $8.7M | -7% | 5.0M | 1.75 |
|
| Moderna (MRNA) | 0.4 | $8.1M | -40% | 160k | 50.80 |
|
| Viking Therapeutics (VKTX) | 0.4 | $7.8M | NEW | 239k | 32.54 |
|
| Icon SHS (ICLR) | 0.4 | $7.6M | -28% | 69k | 110.66 |
|
| Xenon Pharmaceuticals (XENE) | 0.4 | $7.5M | -43% | 130k | 58.15 |
|
| PerkinElmer (RVTY) | 0.4 | $7.4M | -47% | 85k | 87.61 |
|
| Agios Pharmaceuticals (AGIO) | 0.4 | $6.8M | NEW | 200k | 33.83 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $6.7M | +8% | 138k | 48.20 |
|
| Bio-techne Corporation (TECH) | 0.3 | $6.6M | -66% | 126k | 52.26 |
|
| Glaukos (GKOS) | 0.3 | $6.5M | -59% | 60k | 107.66 |
|
| Tenet Healthcare Corp Com New (THC) | 0.3 | $5.6M | NEW | 30k | 188.71 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $5.2M | NEW | 10k | 523.47 |
|
| Intuitive Surgical Com New (ISRG) | 0.3 | $5.1M | -38% | 11k | 460.99 |
|
| Praxis Precision Medicines I Com New Put Option (PRAX) | 0.3 | $4.8M | NEW | 15k | 322.19 |
|
| Esperion Therapeutics (ESPR) | 0.3 | $4.8M | -54% | 1.7M | 2.74 |
|
| Molina Healthcare (MOH) | 0.2 | $4.4M | -27% | 33k | 133.30 |
|
| Healthequity (HQY) | 0.2 | $4.3M | -72% | 52k | 83.57 |
|
| Bruker Corporation (BRKR) | 0.2 | $4.2M | -85% | 117k | 36.12 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.2 | $3.9M | NEW | 184k | 21.44 |
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 0.2 | $3.8M | -69% | 30k | 127.73 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $3.7M | NEW | 678k | 5.53 |
|
| Centene Corporation (CNC) | 0.2 | $3.7M | -65% | 112k | 32.74 |
|
| Acasti Pharma (GRCE) | 0.2 | $3.5M | NEW | 757k | 4.63 |
|
| Engene Holdings | 0.2 | $3.5M | +12% | 511k | 6.81 |
|
| Universal Hlth Svcs CL B Put Option (UHS) | 0.2 | $3.3M | NEW | 18k | 178.97 |
|
| Enhabit Ord | 0.2 | $3.2M | +4% | 228k | 14.09 |
|
| Select Sector Spdr Tr State Street Ene Call Option (XLE) | 0.2 | $3.1M | NEW | 50k | 61.26 |
|
| Definium Therapeutics Com Shs (DFTX) | 0.2 | $3.0M | NEW | 161k | 18.90 |
|
| Equillium (EQ) | 0.2 | $3.0M | NEW | 1.5M | 2.00 |
|
| Ensign (ENSG) | 0.2 | $3.0M | NEW | 15k | 201.50 |
|
| Replimune Group Call Option (REPL) | 0.2 | $3.0M | NEW | 387k | 7.65 |
|
| Adagio Therapeutics (IVVD) | 0.2 | $3.0M | +6% | 2.3M | 1.30 |
|
| Pmv Pharmaceuticals (PMVP) | 0.2 | $2.9M | NEW | 2.3M | 1.24 |
|
| Alector (ALEC) | 0.2 | $2.9M | +34% | 1.4M | 2.15 |
|
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $2.8M | NEW | 125k | 22.48 |
|
| Relay Therapeutics (RLAY) | 0.1 | $2.7M | -44% | 271k | 9.95 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 0.1 | $2.5M | NEW | 100k | 24.66 |
|
| Lipocine Com New (LPCN) | 0.1 | $2.4M | NEW | 295k | 7.99 |
|
| Vir Biotechnology (VIR) | 0.1 | $2.2M | NEW | 250k | 8.96 |
|
| Anteris Technologies Global (AVR) | 0.1 | $2.2M | -19% | 401k | 5.55 |
|
| Amarin Corp Sponsored Adr (AMRN) | 0.1 | $2.1M | -14% | 148k | 14.46 |
|
| Savara (SVRA) | 0.1 | $2.1M | +125% | 384k | 5.46 |
|
| Relmada Therapeutics (RLMD) | 0.1 | $1.9M | NEW | 278k | 6.96 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $1.9M | +6% | 146k | 13.06 |
|
| Sutro Biopharma Com Shs (STRO) | 0.1 | $1.8M | -62% | 73k | 24.91 |
|
| Inovio Pharmaceuticals Com Shs (INO) | 0.1 | $1.8M | NEW | 1.0M | 1.74 |
|
| Surrozen Com New (SRZN) | 0.1 | $1.7M | -38% | 59k | 29.13 |
|
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $1.7M | NEW | 300k | 5.57 |
|
| Inflarx Nv (IFRX) | 0.1 | $1.6M | 1.8M | 0.89 |
|
|
| Anaptysbio Inc Common (ANAB) | 0.1 | $1.5M | -77% | 27k | 55.46 |
|
| Novocure Ord Shs (NVCR) | 0.1 | $1.5M | +11% | 135k | 10.90 |
|
| Bioventus Com Cl A (BVS) | 0.1 | $1.5M | -66% | 159k | 9.13 |
|
| Agilon Health Com New (AGL) | 0.1 | $1.4M | NEW | 177k | 7.91 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $1.3M | -80% | 63k | 20.95 |
|
| Evommune Com Shs (EVMN) | 0.1 | $1.3M | NEW | 55k | 22.99 |
|
| Immunocore Hldgs Ads (IMCR) | 0.1 | $1.2M | NEW | 39k | 30.15 |
|
| Assembly Biosciences Com New (ASMB) | 0.1 | $1.1M | -74% | 41k | 27.75 |
|
| Pliant Therapeutics (PLRX) | 0.1 | $1.1M | +5% | 891k | 1.26 |
|
| Silverback Therapeutics (SPRY) | 0.1 | $1.1M | -45% | 136k | 8.03 |
|
| Aadi Bioscience (WHWK) | 0.1 | $1.1M | +17% | 307k | 3.45 |
|
| Tyra Biosciences (TYRA) | 0.1 | $1.0M | -90% | 27k | 38.30 |
|
| Passage Bio Com New (PASG) | 0.1 | $1.0M | +4% | 132k | 7.85 |
|
| Diversified Healthcare Tr Com Sh Ben Int (DHC) | 0.1 | $1.0M | NEW | 151k | 6.64 |
|
| Inmode SHS (INMD) | 0.0 | $927k | +9% | 68k | 13.68 |
|
| Capital Sr Living Corp (SNDA) | 0.0 | $917k | NEW | 28k | 32.25 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $885k | +6% | 191k | 4.64 |
|
| Editas Medicine (EDIT) | 0.0 | $719k | 291k | 2.47 |
|
|
| Ss Innovations International Com New (SSII) | 0.0 | $551k | +46% | 110k | 5.00 |
|
| Retractable Technologies (RVP) | 0.0 | $384k | 581k | 0.66 |
|
|
| eHealth (EHTH) | 0.0 | $285k | 221k | 1.29 |
|
|
| Selectquote Ord (SLQT) | 0.0 | $225k | 358k | 0.63 |
|
|
| Airsculpt Technologies (AIRS) | 0.0 | $210k | NEW | 74k | 2.83 |
|
Past Filings by Eversept Partners
SEC 13F filings are viewable for Eversept Partners going back to 2017
- Eversept Partners 2026 Q1 filed May 15, 2026
- Eversept Partners 2025 Q4 filed Feb. 17, 2026
- Eversept Partners 2025 Q3 filed Nov. 14, 2025
- Eversept Partners 2025 Q2 filed Aug. 14, 2025
- Eversept Partners 2025 Q1 filed May 15, 2025
- Eversept Partners 2024 Q4 filed Feb. 14, 2025
- Eversept Partners 2024 Q3 filed Nov. 14, 2024
- Eversept Partners 2024 Q2 filed Aug. 14, 2024
- Eversept Partners 2024 Q1 filed May 15, 2024
- Eversept Partners 2023 Q4 filed Feb. 14, 2024
- Eversept Partners 2023 Q3 filed Nov. 14, 2023
- Eversept Partners 2017 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q1 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q2 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q3 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q4 restated filed Nov. 8, 2023